Image Credit: STAT News
STAT+: Arrakis CEO cites ‘cul-de-sacs’ on road to RNA-intercepting cancer drugs
.@ArrakisTx was formed to create RNA-intercepting drugs to fight cancer. Despite some promising data, CEO @michael_gilman says it will shift targets.